Delhi High Court restrains Cipla from infringing Novartis’ respiratory drug

Upholding Justice Manmohan Singh's order of January 2015, the division bench of Badar Durrez Ahmed andĀ Sanjeev Sachdeva, JJ. of theĀ Delhi High Court today restrained Cipla from infringing Novartis' patent on its drug Indacaterol - marketed under the name "Onbrez".

Onbrez is a respiratory drug, which provides relief to persons suffering from Chronic Obstructive Pulmonary Disease (COPD). It is a drug manufactured by the Swiss company in Switzerland and imported into India by Lupin . . .

Facebook Comment